0000950123-14-002352.txt : 20140214 0000950123-14-002352.hdr.sgml : 20140214 20140214084706 ACCESSION NUMBER: 0000950123-14-002352 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20131231 FILED AS OF DATE: 20140214 DATE AS OF CHANGE: 20140214 EFFECTIVENESS DATE: 20140214 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Abingworth LLP CENTRAL INDEX KEY: 0001397144 IRS NUMBER: 980518585 STATE OF INCORPORATION: X0 FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-14285 FILM NUMBER: 14610755 BUSINESS ADDRESS: STREET 1: 38 JERMYN STREET CITY: LONDON STATE: X0 ZIP: SW1Y 6DN BUSINESS PHONE: 44 (0)20 7534 1500 MAIL ADDRESS: STREET 1: 38 JERMYN STREET CITY: LONDON STATE: X0 ZIP: SW1Y 6DN 13F-HR 1 primary_doc.xml 13F-HR LIVE false true false 0001397144 XXXXXXXX 12-31-2013 12-31-2013 ABINGWORTH LLP
38 JERMYN STREET LONDON X0 SW1Y 6DN
13F HOLDINGS REPORT 028-14285 Abingworth Management LTD N
John Heard General Counsel 44 2075341508 /s/ John Heard London X0 02-14-2014 1 11 132699 false 1 Abingworth Management LTD
INFORMATION TABLE 2 form13fInfoTable.xml INFORMATION TABLE FOR FORM 13F Amarin Spons ADR 023111206 15851 8087486 SH DFND 8087486 0 0 Anthera Common 03674U102 1340 437994 SH DFND 437995 0 0 Cempra Common 15130J109 8850 714285 SH DFND 714285 0 0 GW Pharma Spons ADR 36197T103 4248 102200 SH DFND 102200 0 0 Hyperion Common 44915N101 1259 62500 SH DFND 62500 0 0 Oncogenex Pharma Common 68230A106 5035 603740 SH DFND 603740 0 0 Portola Common 737010108 31953 1240912 SH DFND 1 1240917 0 0 Prosensa Common N71546100 28957 6213924 SH DFND 1 6213924 0 0 Supernus Common 868459108 27108 3600000 SH DFND 1 3600000 0 0 Zalicus Common 98887C105 87 78966 SH DFND 473800 0 0 Zogenix Common 98978L105 8010 2335218 SH DFND 1 2335218 0 0